We Help Companies Find New Sales Opportunities
Xenova has sold its biopharmaceuticals manufacturing facility in Canada to QSV Biologicals for £3m.
Xenova has announced a £8.5m takeover bid for KS Biomedix, and expects to raise at least £9m in a share issue to fund the development of KSB's leading drug.
Xenova is to acquire Cantab Pharmaceuticals, the Cambridge-based vaccines company, for £53m.
Xenova is seeking a merger partner in order to further the development of its biotechnology-based products.
Xenova is to sell MetaXen, its US-based drugs software business, to Exelixis Pharmaceuticals for £0.2m.
Xenova is selling Discovery, its technology subsidiary, to TerraGen Diversity of Canada for up to £5m.